FDG-PET accurate for evaluating lung tumor destruction from radiofrequency ablation

FDG-PET can be used to assess the amount of tumor destruction after radiofrequency ablation (RFA)--the use of heat to destroy tumors--for the treatment of lung tumors and may provide more valuable information than CT alone, according to a new study.

For the study, researchers assessed 10 tumors in 10 patients who had lung tumors treated with CT-guided RFA and had PET scans both prior to RFA and following RFA. The researchers found that in seven out of 11 RFA treatments for the 10 patients, follow-up PET demonstrated persistent tumor activity. Two of the patients showed no activity on the follow-up PET, suggesting complete destruction of any active tumor. One patient had no definite change in the appearance of the mass, and another had a smaller lesion on follow-up PET.

"Usually, CT is used to assess tumor destruction, but CT cannot tell you whether a tumor is still alive--that is, actively metabolizing glucose--or dead in the area of destruction. It can also be difficult to assess how much of the ablated area is caused by an inflammatory reaction to the procedure. By using PET, the tumor cells that are still alive light up and the radiologist can better assess how much residual active tumor is left," said Jennifer Daly, MD, of the Newton-Wellesley Hospital in Newton, MA, and lead author of the study.

According to the researchers, without effective follow-up imaging, the radiologist has to gauge how successful it was based only on the patient's improvement in pain and maybe what is possibly seen on a post-ablation CT. "You don't really know for sure how much active tumor is destroyed unless you compare pre- and post-PET scans," said Dr. Daly.

The full results of the study will be presented on Monday, May 1, 2006 during the American Roentgen Ray Society Annual Meeting in Vancouver, BC.


Contact: Necoya Lightsey
American Roentgen Ray Society

Page: 1

Related medicine news :

1. Dynamic sonography accurate in diagnosing muscle tears
2. Simple system accurately predicts weight-loss surgery risk
3. Prematurity more accurately predicted by advances in proteomic technology
4. MR angiography highly accurate in detecting blocked arteries
5. Imaging technique is highly accurate in diagnosing, locating pancreas defects in newborns
6. Prediction markets accurately forecast influenza activity
7. Workers compensation ratings dont accurately predict disabilities
8. Hospital performance measures may not accurately reflect quality of care or predict patient outcomes
9. New GreeneChip identifies multiple pathogens rapidly and accurately
10. GreeneChip -- New diagnostic tool that rapidly and accurately identifies multiple pathogens
11. Inexpensive test detects H5N1 infections quickly and accurately

Post Your Comments:

(Date:10/13/2015)... ... October 13, 2015 , ... Sir Grout of Greater ... the local Boston chapter of Ronald McDonald House Charities® (RMHC®). This donation was made ... Sir Grout of Greater Boston since its inception. , “We believe strongly in the ...
(Date:10/13/2015)... ... 13, 2015 , ... HealthAware , headquartered in Denver, ... Engagement Summit . HealthAware is a technology company focused on the patient journey: ... mobile devices that provide a framework for the development of healthy habits and ...
(Date:10/13/2015)... (PRWEB) , ... October 13, 2015 , ... ... solution provider of IBM software products, introduced a new company, RightSensor™ LLC, an ... and data communications capability. RightSensor™ provides a fully-managed approach for customers requiring ...
(Date:10/13/2015)... New York, NY (PRWEB) , ... October 13, 2015 , ... ... Android®. The app helps individuals find others to train with, participate in local fitness ... the App Store and Google Play. , “As high medical costs drive us to ...
(Date:10/13/2015)... ... October 13, 2015 , ... ... the unique health needs of new moms. Postnatal Omega-3, which has been ... ), utilizes Nordic Naturals’ exclusive, new, ultra-concentrated omega-3 oil. This breakthrough oil ...
Breaking Medicine News(10 mins):
(Date:10/13/2015)... Calif. , Oct. 13, 2015  Asterias ... agreement with the UK-based Cell Therapy Catapult to ... AST-VAC2, Asterias, allogeneic dendritic cell immunotherapy. Under the ... scale manufacturing processes for AST-VAC2 to support advanced ... --> --> The ...
(Date:10/12/2015)... -- Use this report to: - Learn ... the medical membrane devices market. - Analyze the present ... medical membrane devices market including hemodialyzers, membrane oxygenators, intravenous ... devices. - Gain information on newly approved products, recalls ... Use this report to: - Learn about the performance, ...
(Date:10/12/2015)... Texas , Oct. 12, 2015  Luminex Corporation (NASDAQ: ... results for the third quarter ended September 30, 2015 on ... is scheduled for release after the close of trading. ... hold a conference call to discuss the operating highlights and ... on November 2, 2015, at 4:30 p.m. Eastern time. ...
Breaking Medicine Technology:
Cached News: